• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米糖复合物配方延长了血管内皮生长因子在肺部的滞留时间。

Nanoglycan complex formulation extends VEGF retention time in the lung.

机构信息

Harvard School of Engineering and Applied Sciences, 29 Oxford Street, Cambridge, Massachussets 02138, USA.

出版信息

Biomacromolecules. 2010 Jul 12;11(7):1863-72. doi: 10.1021/bm100384z.

DOI:10.1021/bm100384z
PMID:20575564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2929700/
Abstract

To extend the retention time of aerosol-delivered growth factors in the lung for stem cell homing/activation purposes, we examined a formulation of vascular endothelial growth factor (VEGF) complexed to dextran sulfate (DS) and chitosan (CS) polyelectrolytes. Optimal incorporation of VEGF was found at a VEGF/DS/CS ratio of 0.12:1:0.33, which resulted in nanoparticle complexes with diameters of 612+/-79 nm and zeta potentials of -31+/-1 mV. The complexes collapsed in physiological solution, and released VEGF in a biphasic time course in vitro. In rat lungs, however, VEGF delivered in the complex was cleared at a constant exponential decay rate, 8-fold slower than that delivered in free form. The extended VEGF retention was likely due to equilibrium binding of VEGF to DS and to endogenous glycosaminoglycans. A similar retention effect is expected with other glycosaminoglycans-binding proteins (including many growth factors) when complexed with these glycans. Owing to its unique application, this type of complex is, perhaps, better described as a nanoglycan complex.

摘要

为了延长气溶胶递送的生长因子在肺部中的滞留时间,以促进干细胞归巢/激活,我们研究了将血管内皮生长因子(VEGF)与葡聚糖硫酸酯(DS)和壳聚糖(CS)聚电解质复合的制剂。在 VEGF/DS/CS 比为 0.12:1:0.33 时,发现 VEGF 的最佳掺入量,这导致纳米颗粒复合物的直径为 612+/-79nm,且 ζ 电位为-31+/-1mV。该复合物在生理溶液中塌陷,并在体外以两相时程释放 VEGF。然而,在大鼠肺部中,以复合物形式递送的 VEGF 以恒定的指数衰减率被清除,比以游离形式递送的速度慢 8 倍。这种延长的 VEGF 保留可能是由于 VEGF 与 DS 和内源性糖胺聚糖的平衡结合所致。当与这些糖结合时,其他与糖胺聚糖结合的蛋白质(包括许多生长因子)预计也会产生类似的保留效果。由于其独特的应用,这种类型的复合物或许可以更好地描述为纳米糖复合物。

相似文献

1
Nanoglycan complex formulation extends VEGF retention time in the lung.纳米糖复合物配方延长了血管内皮生长因子在肺部的滞留时间。
Biomacromolecules. 2010 Jul 12;11(7):1863-72. doi: 10.1021/bm100384z.
2
Incorporation of heparin-binding proteins into preformed dextran sulfate-chitosan nanoparticles.将肝素结合蛋白掺入预先形成的硫酸葡聚糖-壳聚糖纳米颗粒中。
Int J Nanomedicine. 2016 Nov 18;11:6149-6159. doi: 10.2147/IJN.S119174. eCollection 2016.
3
Preparation and characterization of SDF-1α-chitosan-dextran sulfate nanoparticles.基质细胞衍生因子-1α-壳聚糖-硫酸葡聚糖纳米粒的制备与表征
J Vis Exp. 2015 Jan 22(95):52323. doi: 10.3791/52323.
4
Polyelectrolyte complexes stabilize and controllably release vascular endothelial growth factor.聚电解质复合物可稳定并可控地释放血管内皮生长因子。
Biomacromolecules. 2007 May;8(5):1607-14. doi: 10.1021/bm061211k. Epub 2007 Apr 12.
5
New nasal nanocomplex self-assembled from charged biomacromolecules: N,N,N-Trimethyl chitosan and dextran sulfate.由带电生物大分子自组装而成的新型鼻腔纳米复合物:N,N,N-三甲基壳聚糖和硫酸葡聚糖。
Int J Biol Macromol. 2016 Jul;88:476-90. doi: 10.1016/j.ijbiomac.2016.03.045. Epub 2016 Mar 24.
6
Controlled release of chitosan/heparin nanoparticle-delivered VEGF enhances regeneration of decellularized tissue-engineered scaffolds.壳聚糖/肝素纳米颗粒递送 VEGF 的控释增强脱细胞组织工程支架的再生。
Int J Nanomedicine. 2011;6:929-42. doi: 10.2147/IJN.S18753. Epub 2011 May 2.
7
Designing chitosan-dextran sulfate nanoparticles using charge ratios.利用电荷比设计壳聚糖-硫酸葡聚糖纳米颗粒。
AAPS PharmSciTech. 2007 Nov 30;8(4):E98. doi: 10.1208/pt0804098.
8
Enhanced immune response against pertussis toxoid by IgA-loaded chitosan-dextran sulfate nanoparticles.壳聚糖-葡聚糖硫酸酯纳米粒载免疫球蛋白 A 增强对百日咳毒素的免疫应答。
J Pharm Sci. 2012 Jan;101(1):233-44. doi: 10.1002/jps.22763. Epub 2011 Sep 22.
9
Delivery of expression constructs of secreted frizzled-related protein 4 and its domains by chitosan-dextran sulfate nanoparticles enhances their expression and anti-cancer effects.壳聚糖-葡聚糖硫酸酯纳米粒递送卷曲相关蛋白 4 及其结构域的表达构建体可增强其表达和抗癌作用。
Mol Cell Biochem. 2018 Jun;443(1-2):205-213. doi: 10.1007/s11010-017-3225-4. Epub 2017 Nov 28.
10
SDF-1α in glycan nanoparticles exhibits full activity and reduces pulmonary hypertension in rats.糖纳米颗粒中的 SDF-1α 表现出完全的活性,并降低了大鼠的肺动脉高压。
Biomacromolecules. 2013 Nov 11;14(11):4009-20. doi: 10.1021/bm401122q. Epub 2013 Oct 18.

引用本文的文献

1
A crosslinked dextran sulfate-chitosan nanoparticle for delivery of therapeutic heparin-binding proteins.用于递送治疗性肝素结合蛋白的交联葡聚糖硫酸酯-壳聚糖纳米颗粒。
Int J Pharm. 2021 Dec 15;610:121287. doi: 10.1016/j.ijpharm.2021.121287. Epub 2021 Nov 11.
2
Incorporation of heparin-binding proteins into preformed dextran sulfate-chitosan nanoparticles.将肝素结合蛋白掺入预先形成的硫酸葡聚糖-壳聚糖纳米颗粒中。
Int J Nanomedicine. 2016 Nov 18;11:6149-6159. doi: 10.2147/IJN.S119174. eCollection 2016.
3
Preparation and characterization of SDF-1α-chitosan-dextran sulfate nanoparticles.基质细胞衍生因子-1α-壳聚糖-硫酸葡聚糖纳米粒的制备与表征
J Vis Exp. 2015 Jan 22(95):52323. doi: 10.3791/52323.
4
SDF-1α in glycan nanoparticles exhibits full activity and reduces pulmonary hypertension in rats.糖纳米颗粒中的 SDF-1α 表现出完全的活性,并降低了大鼠的肺动脉高压。
Biomacromolecules. 2013 Nov 11;14(11):4009-20. doi: 10.1021/bm401122q. Epub 2013 Oct 18.
5
Preparation and characterization of ferrofluid stabilized with biocompatible chitosan and dextran sulfate hybrid biopolymer as a potential magnetic resonance imaging (MRI) T2 contrast agent.用生物相容性壳聚糖和葡聚糖硫酸酯杂化生物聚合物稳定的铁磁流体的制备和特性,作为一种潜在的磁共振成像(MRI)T2 对比剂。
Mar Drugs. 2012 Oct 29;10(11):2403-14. doi: 10.3390/md10112403.
6
Regenerative pulmonary medicine: potential and promise, pitfalls and challenges.再生医学:潜力与前景、陷阱与挑战。
Eur J Clin Invest. 2012 Aug;42(8):900-13. doi: 10.1111/j.1365-2362.2012.02667.x. Epub 2012 Mar 21.

本文引用的文献

1
The heparin-binding domain confers diverse functions of VEGF-A in development and disease: a structure-function study.肝素结合结构域赋予 VEGF-A 在发育和疾病中的多种功能:一项结构-功能研究。
Biochem Soc Trans. 2009 Dec;37(Pt 6):1201-6. doi: 10.1042/BST0371201.
2
Stem cells and cell therapies in lung biology and lung diseases.肺生物学与肺部疾病中的干细胞及细胞疗法
Proc Am Thorac Soc. 2008 Jul 15;5(5):637-67. doi: 10.1513/pats.200804-037DW.
3
Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells.人脐带血来源间充质干细胞向肺上皮细胞的分化
Am J Respir Crit Care Med. 2008 Apr 1;177(7):701-11. doi: 10.1164/rccm.200706-859OC. Epub 2007 Dec 6.
4
Epithelial-vascular cross talk mediated by VEGF-A and HGF signaling directs primary septae formation during distal lung morphogenesis.由血管内皮生长因子A(VEGF-A)和肝细胞生长因子(HGF)信号介导的上皮-血管相互作用指导远端肺形态发生过程中的初级隔膜形成。
Dev Biol. 2007 Aug 1;308(1):44-53. doi: 10.1016/j.ydbio.2007.04.042. Epub 2007 May 3.
5
Polyelectrolyte complexes stabilize and controllably release vascular endothelial growth factor.聚电解质复合物可稳定并可控地释放血管内皮生长因子。
Biomacromolecules. 2007 May;8(5):1607-14. doi: 10.1021/bm061211k. Epub 2007 Apr 12.
6
Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease.支气管肺发育不良:血管都去哪儿了?血管生成生长因子在慢性肺病中的作用
Am J Respir Crit Care Med. 2007 May 15;175(10):978-85. doi: 10.1164/rccm.200611-1660PP. Epub 2007 Feb 1.
7
Structural and functional basis of CXCL12 (stromal cell-derived factor-1 alpha) binding to heparin.CXCL12(基质细胞衍生因子-1α)与肝素结合的结构和功能基础。
J Biol Chem. 2007 Mar 30;282(13):10018-10027. doi: 10.1074/jbc.M608796200. Epub 2007 Jan 29.
8
VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells.血管内皮生长因子诱导的成人血管新生:辅助细胞的募集、留存及作用
Cell. 2006 Jan 13;124(1):175-89. doi: 10.1016/j.cell.2005.10.036.
9
A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors.一种制备用于生长因子控释的肝素功能化纳米颗粒的简便方法。
Biomaterials. 2006 Apr;27(12):2621-6. doi: 10.1016/j.biomaterials.2005.11.043. Epub 2005 Dec 19.
10
Expression and characterization of human vascular endothelial growth factor (VEGF165) in insect cells.人血管内皮生长因子(VEGF165)在昆虫细胞中的表达与特性分析
Protein Expr Purif. 2006 Apr;46(2):503-9. doi: 10.1016/j.pep.2005.09.023. Epub 2005 Oct 26.